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introduction: Surgical treatment of malignant thoracic wall tumors represents a for-
midable challenge. In particular, locally advanced tumors that have already infiltrated 
critical anatomic structures are associated with a high surgical morbidity and can result 
in full-thickness defects of the thoracic wall. Plastic surgery can reduce this surgical 
morbidity by reconstructing the thoracic wall through various tissue transfer techniques. 
Sufficient soft-tissue reconstruction of the thoracic wall improves quality of life and miti-
gates functional impairment after extensive resection. The aim of this article is to illustrate 
the various plastic surgery treatment options in the multimodal therapy of patients with 
malignant thoracic wall tumors.
Materials and methods: This article is based on a review of the current literature and 
the evaluation of a patient database.
Results: Several plastic surgical treatment options can be implemented in the curative 
and palliative therapy of patients with malignant solid tumors of the chest wall. Large 
soft-tissue defects after tumor resection can be covered by local, pedicled, or free flaps. 
In cases of large full-thickness defects, flaps can be combined with polypropylene mesh 
to improve chest wall stability and to maintain pulmonary function. The success of mod-
ern medicine has resulted in an increasing number of patients with prolonged survival 
suffering from locally advanced tumors that can be painful, malodorous, or prone to 
bleeding. Resection of these tumors followed by thoracic wall reconstruction with viable 
tissue can substantially enhance the quality of life of these patients.
Discussion: In curative treatment regimens, chest wall reconstruction enables complete 
resection of locally advanced tumors and subsequent adjuvant radiotherapy. In palliative 
disease treatment, plastic surgical techniques of thoracic wall reconstruction provide 
palliation of tumor-associated morbidity and can therefore improve patients’ quality of life.
Keywords: thoracic wall, chest wall, tumor, sarcoma, breast cancer, reconstruction, flaps
iNTRODUCTiON
The majority of thoracic wall defects result from the surgical resection of malignant tumors during 
curative or palliative attempts. These malignant tumors arise from all different anatomic structures 
of the thoracic wall and consequently vary in pathology and prognosis. Solid malignancies of the 
thoracic wall include primary thoracic wall tumors and metastatic lesions as well as locally invading 
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malignancies from adjacent tissues and organs, such as breast 
cancer, lung cancer, mediastinal neoplasms, and mesothelioma. 
The most common primary thoracic wall tumors are bone and 
soft-tissue sarcomas. Approximately 55% of the primary malig-
nant chest wall tumors arise from the bone or cartilage, whereas 
45% originate from the soft tissue (1, 2). Chondrosarcomas are 
the most common skeletal malignancies of the thoracic wall 
and commonly occur in the anterior thoracic wall (3). In the 
heterogeneous group of soft-tissue sarcomas, not otherwise 
specified sarcomas (NOS) and liposarcomas are known to be the 
most frequent primary soft-tissue sarcomas of the thoracic wall 
(4). Notably, the incidence of radiation-induced angiosarcomas 
of the chest wall is increasing due to the prolonged survival of 
women irradiated for primary breast cancer and will present a 
therapeutic challenge in the future (5). In patients with primary 
chest wall tumors and radiation-induced angiosarcomas, nearly 
all treatment regimens involve the surgical resection of the tumor 
with clear margins, usually followed by adjuvant radiation and/
or chemotherapy depending on the histologic entity. However, 
surgical resection and reconstruction of the thoracic wall are 
also suitable for other patients besides those with primary 
tumors. Increasing knowledge in all fields of modern medicine 
and effective treatment modalities for different types of cancer 
continuously increase the survival of patients with metastatic 
or locally advanced disease stage. The incidence of metastatic 
lesions of the chest wall and locally invading tumors from the 
breast and lung will become more frequent in the future. Thus, 
palliative treatment options with as little perioperative morbidity 
as possible will become increasingly important. In this palliative 
setting, resection of painful, odor-intensive, and bleeding tumors 
with subsequent thoracic wall reconstruction seems to be a 
valid option to increase the quality of life at least for a period of 
time. Hence, careful planning and individualized treatment are 
particularly important in these patients to provide a safe and fast 
recovery.
Nevertheless, partial- and full-thickness thoracic wall resec-
tions combined with reconstruction still represent a formidable 
surgical challenge, but improvements in surgical technique, 
intensive care, and rehabilitation have led to reduced periopera-
tive morbidity and mortality (6, 7). In the surgical field, plastic 
surgery procedures enable oncologic tumor resection, recon-
struction of the thoracic wall, and adjuvant radiotherapy by 
improving the local tissue situation (8). Moreover, plastic surgical 
reconstruction of the thoracic wall provides sufficient stability to 
maintain pulmonary function. Pulmonary function parameters 
are reduced only moderately and are not significantly affected by 
the size of the resection or its location (9).
In the following article, we will discuss the different options 
for thoracic wall reconstruction after oncological resection by 
examining a series of cases from our institution and a review of 
the literature.
PReOPeRATive evALUATiON
Preoperative evaluation should be performed properly and in a 
multidisciplinary manner with pulmonary and cardiac function 
tests. In particular, patients with chronic obstructive pulmonary 
disease should be treated preoperatively to optimize pulmonary 
function before surgery. Postoperatively, patients with cardiac or 
pulmonary disorders should be treated in the intensive care unit, 
and early extubation and active respiratory therapy should be the 
most important treatment goals. Chest X-ray, CT, and MRI can be 
used as diagnostic tools to assess the imaging appearance of tho-
racic wall tumors. CT can provide additional information about 
calcification, bone destruction, and vascularity of the tumor, 
whereas MRI provides more soft-tissue details. Precise radiologi-
cal examination with detailed information about tumor location 
and extent is essential for proper surgical planning and manage-
ment as well as preoperative histologic evaluation. CT-controlled 
biopsy and incisional biopsy can be used as suitable modalities 
of tissue obtainment. Preoperative histologic examination is 
mandatory and should be performed in any lesions suspected to 
be malignant.
ReSeCTiON
In a curative setting, the aim of surgical treatment is the resection 
of the tumor with microscopically negative margins. Appropriate 
oncologic resection should not be compromised because of con-
cern for the resulting thoracic wall defect. However, the extent 
of surgical margin width is determined by the chest wall tumor 
histology. In soft-tissue sarcomas, there has been a shift of the 
paradigms regarding the width of surgical resection from radical 
wide resections to more marginal resections (10–12). In the sur-
gical treatment of primary soft-tissue sarcomas of the chest wall, 
negative surgical margins were not significantly associated with 
prolonged overall survival when compared with positive margins 
(7, 13). However, the attainment of microscopically negative 
margins should be the goal of surgical resection to improve local 
control and to prevent local recurrence (14), but, to date, there 
is no reasonable evidence for radical surgical approach in most 
soft-tissue sarcomas, for which marginal resections seem to be 
sufficient for local disease control (12).
Complete surgical resection with negative margins also 
remains the mainstay of therapy in the curative treatment of other 
malignancies that are still localized and not disseminated, such 
as locally advanced breast carcinomas. Thoracic wall resection 
and reconstruction have been proven to be a safe and effective 
procedure in patients with advanced, locally recurrent breast 
carcinomas (15).
As mentioned earlier, increasing numbers of patients present 
with a disseminated disease stage and are not suitable for a 
curative approach. In these patients, surgical treatment should 
be considered carefully and every attempt should be made to 
minimize perioperative morbidity. Tumor debulking and reliable 
soft-tissue coverage can alleviate pain and suffering for at least a 
period of time.
THORACiC wALL ReCONSTRUCTiON 
wiTH MeSH AND COMPOSiTe iMPLANTS
Depending on the extent of the malignant tumor, adequate onco-
logic resection can result in partial- or full-thickness thoracic 
wall defects. Full-thickness defects, which involve all tissue layers 
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including soft tissue and bony structures, should be reconstructed 
immediately during the same surgery to protect the subjacent 
organs and to enable quick recovery. In this procedure, thoracic 
wall reconstruction should obliterate dead space and provide 
adequate soft-tissue coverage and stability, without compromis-
ing respiratory biomechanics. For this purpose, synthetic nets can 
be utilized to improve chest wall stability and to avoid herniation 
of intrathoracic organs. These nets should be both robust and 
pliable. In recent decades, synthetic nets have included essential 
features such as inertness, radiolucency, sufficient rigidity, and 
pliability. At our institution, we have had successful experiences 
with non-absorbable polypropylene meshes. However, different 
synthetic nets are now available, but none of them have proven 
to be significantly superior (16–18). The decision as to whether 
synthetic nets should be utilized depends on several factors, 
which include not only defect area and depth but also rigidity 
of the chosen flap coverage, location, wound contamination, and 
skin texture after previous radiation. It is widely accepted that 
defects exceeding more than four ribs at the lateral chest wall are 
associated with higher risks of herniation and paradox breathing 
and therefore should additionally be reconstructed with synthetic 
nets (8, 19–22). However, the closer the defect to the apex of the 
thoracic wall, the more suspension is provided by the sternum, 
scapula, and clavicula, and even larger defects might be recon-
structed without additional synthetic material (23). Similarly, an 
irradiated chest wall may provide enough rigidity to avoid addi-
tional mesh implantation. Nevertheless, irradiated tissue should 
be replaced as far as possible by healthy tissue to allow proper 
healing and, if necessary, subsequent radiation (24). Notably, 
synthetic nets should be avoided in contaminated wound defects 
and should be implanted subsequently under clean wound condi-
tions. Alternatively, if quick coverage and adequate stability can 
be achieved during the same surgical procedure, chest wall recon-
struction can be performed with a stable, muscular flap, such as 
the latissimus dorsi flap, which is discussed below. In patients 
with simultaneous irradiated soft-tissue defects and infections in 
the chest wall area, such as pleural empyema, we usually debride 
and cover the defects with pedicled latissimus dorsi flaps without 
synthetic mesh implantation during one surgical procedure.
To maintain chest wall rigidity and to improve functional as 
well as cosmetic outcomes after large anterior and lateral resec-
tions, several authors have recommended the use of composite 
implant techniques (16, 21, 25–28). The most common composite 
is the combination of polypropylene meshes and methylmeth-
acrylate substitutes in the form of a “sandwich” prosthesis. Here, 
a first layer of polypropylene mesh is positioned straight on the 
base of the defect and the methylmethacrylate substitute is then 
added and molded to the pattern of the defect. A second layer of 
polypropylene mesh is placed on top of the methylmethacrylate 
substitute, which hardens in an exothermic reaction. This com-
posite implant technique allows for the reconstruction of the 
original contours of the chest wall and can be performed as a 
one-stage surgical procedure for major anterior and lateral chest 
wall defects to prevent paradoxical movement and overcome 
deformities. However, methylmethacrylate substitutes are not 
permeable to fluids and, hence, are considered to increase the 
risk of infections (29). Nevertheless, several case series and a 
retrospective analysis of 112 patients with polypropylene mesh/
methylmethacrylate composites have demonstrated quite good 
functional results without increased infection rates (16, 26, 28). 
Weyant and colleagues have reported no significant difference 
between large chest wall defects reconstructed with polypropylene 
mesh/methylmethacrylate composite and small chest wall defects 
reconstructed with polypropylene mesh with regard to respiratory 
complications (28). Other composite implant techniques, includ-
ing silicone, rubber, carbon fiber, and polytetrafluoroethylene 
(PTFE), have been described in case reports (21, 29–31). There 
have also been reports on the safe use of titanium implants in the 
reconstruction of the chest wall after tumor resection (32–34). In 
19 patients with large anterior and lateral full-thickness defects 
after tumor resection, Berthet et al. have reconstructed the chest 
wall via a combination of titanium rib osteosynthesis and PTFE 
mesh in a one-step procedure (32). There were two cases of 
infection and one patient with a major complication in the form 
of respiratory failure. More recently, the improvements in 3D 
prototyping technology by selective laser sintering have enabled 
the production of more complex and detailed custom-made 
titanium implants. In this regard, Turna et al. have presented a 
case in which an extended anterior chest wall defect after tumor 
resection was safely reconstructed with a customized titanium 
implant in combination with a pedicled latissimus dorsi flap and 
a split-thickness graft (34). However, each material has its own 
advantages and disadvantages. There is still a lack of evidence 
regarding each of these approaches, and further studies are war-
ranted to provide long-term data. The same issue applies to the 
use of allografts and xenografts because the literature on these 
topics remains sparse (21). The decision about which material to 
use ultimately depends on the defect and the surgeon’s experience.
OSTeOSYNTHeSiS
When direct approximation of the sternal edges is possible, osteo-
synthetic procedures can maintain the chest wall stability and 
improve the functional outcome after partial anterior resections. 
Here, several studies have demonstrated that primary sternal 
plating reduces the risk of sternal non-unions and postoperative 
mediastinitis more effectively than does fixation via cerclage 
wires (35–37). If direct sternal fixation is not possible, we bridge 
over the sternal defect with local flaps such as the pectoralis major 
or vertical rectus abdominis muscle (VRAM) flap.
In the following section, we will address the different options 
of plastic surgical soft-tissue coverage that are commonly used at 
our institution.
THORACOePiGASTRiC FLAP
The thoracoepigastric flap is a fasciocutaneous flap pedicled to the 
perforators at the proximity of the midline of the fascia of the mus-
culus rectus abdominis and can be utilized to cover smaller defects 
(Figures  1A–C). Medially based thoracoepigastric flaps receive 
perforator vessels from the epigastric arcade, whereas laterally 
based flaps are supplied by perforators from the intercostal arteries. 
The reliability of the blood supply can be assessed by preoperative 
Doppler imaging. Thoracoepigastric flaps can be raised superior 
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or inferior to the level of the rectus fascia and investing fascia of 
the external oblique musculature (38). Primary donor-site closure 
can be achieved for most of the laterally based flaps, whereas skin 
grafting is often required for medially based thoracoepigastric 
flaps (38, 39). Thoracoepigastric flaps are indicated for the cover-
age of smaller defects located in the lower thoracic region.
PeCTORALiS MAJOR FLAP
The pectoralis major flap can be used as a myocutaneous flap or 
simply as a muscular flap. When used as a myocutaneous flap, a 
skin graft is also taken from the region of the lower breast fold, and 
this graft remains pedicled to the muscle and can be transposed 
into the head and neck region (40). The pectoralis major muscle 
is supplied by a dominant vascular pedicle (arteria thoracoacro-
mialis) and several minor pedicles. The thoracoacromial artery 
presents a consistent and reliable pedicle on which the pectoralis 
major muscle can be completely elevated (41). The pectoralis 
major muscle has also reliable secondary perforators from the 
internal mammary artery allowing medially based propeller flaps 
to cover smaller sternal defects. In chest wall reconstruction, the 
pectoralis major flap is primarily used as a muscle advancement 
or rotation flap to cover defects in the cranial portion of the 
sternum (42). Smaller contralateral defects may also be easily 
reached by this flap (Figures 2A,B and 3A,B). It can also be lifted 
from the thoracic wall as a sliding pectoralis muscle flap. To gain 
more rotatory flexibility, it can be removed from the clavicle and 
the humerus. In this case, it remains pedicled to the pectoral 
branches of the thoracoacromial artery. Upon lifting the muscle, 
there is only a moderate loss of strength (42). However, the size of 
the skin graft is very limited when lifted as a myocutaneous flap, 
and the vascular structure of the flap is often impaired by prior 
operations and radiotherapy. Low sternal and xiphoid defects 
may also be out of reach for the pectoralis major flap.
vRAM FLAP
The VRAM flap is particularly suited for longitudinal anterior 
chest wall defects (43) (Figures  4A,B). Preoperative planning 
should consider any possible removal of the arteria mammaria 
interna in previous coronary artery bypass operations because 
the VRAM flap is primarily supplied by the arteria epigastrica 
superior and arteria mammaria interna. In such cases, the VRAM 
flap can be lifted contralaterally to the place of removal. On rare 
occasions, insufficient venous outflow via the superior epigastric 
vessels can occur. Here, the inferior epigastric vessels at the 
caudal portion of the flap can be connected parasternally to the 
mammaria interna vessels in the sense of vessel supercharging. 
The VRAM flap is particularly indicated when sternal defects 
with large volumes should be covered and when sternal defects 
extend inferiorly to the epigastric areas (41, 44). It is also a reliable 
backup option when defect coverage with the latissimus dorsi flap 
is not possible. In a follow-up study at our institution, abdominal 
hernia and bulging occurred in 13% of all oncological patients 
treated with VRAM flap plasties. No flap loss was observed, and 
the loss of strength was moderate with a slight restriction of 
FiGURe 1 | (A–C) Thoracoepigastric soft-tissue coverage after resection of a 
locally recurrent breast carcinoma (right) with simultaneous, contralateral 
infestation at the left breast.
FiGURe 2 | (A,B) Pectoralis major flap coverage of a central chest wall 
defect after resection of a recurrent sarcoma.
FiGURe 3 | (A,B) Chest wall coverage following tumor resection with VRAM 
flap.
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endurance without decreased maximum strength (45). However, 
the relatively high rates of abdominal hernia have to be consid-
ered, and the indication for local reconstruction with VRAM 
should be weighed carefully, especially in patients in a palliative 
setting where some surgical procedures (e.g., stabilization of the 
abdominal wall) should be avoided.
CRANiALLY PeDiCLeD TRAM FLAP
To cover larger defects, particularly at the anterolateral thorax, the 
VRAM flap can be extended to include a transversal graft from 
the lower abdomen [transverse rectus abdominis myocutaneous 
flap (TRAM)] (Figures 4C and 5A,B). The resulting anchor flap 
can correct defects up to 40 cm in diameter. In the majority of 
cases, the cutaneous donor site should primarily be closed by 
means of an abdominoplasty with umbilical repositioning when 
possible. Depending on the resulting fascia defect, the abdominal 
wall can be reinforced with a polypropylene mesh insert to avoid 
the formation of an abdominal hernia. The perfusion of cranially 
pedicled TRAM flap takes place via the superior epigastric ves-
sels, which are slimmer than the inferior epigastric vessels. Hence, 
in the case of a cranially pedicled flap from the lower abdomen, 
perfusion disorders and partial necrosis can occur, particularly in 
the lateral portions of the flap.
Nevertheless, the cranially pedicled TRAM flap remains a 
reliable option in the armamentarium of soft-tissue coverage, 
especially in the case of extensive tumors of the anterolateral 
chest wall.
LATiSSiMUS DORSi MUSCULAR FLAP
A pedicled latissimus dorsi flap can sufficiently cover most defects 
on the thoracic wall (Figures 5C,D). The latissimus dorsi flap can 
be harvested as a muscle flap, a myocutaneous flap, or a perforator 
flap. The thoracodorsal artery is the dominant pedicle of the latis-
simus dorsi flap and arises from the subscapular artery. Anatomic 
variations are well described and should be considered when rais-
ing the flap (41). After entering the base of the latissimus dorsi 
muscle, the thoracodorsal artery divides into two main branches. 
The upper horizontal branch runs medially along the superior 
border of the muscle and the descending branch runs parallel 
to the anterior border of the muscle (46, 47). The large radius of 
rotation enables large soft-tissue coverage at the anterior chest 
wall, the sternal region, and the upper arm. Due to its reliable 
vascular supply, its proportions, and the moderate donor-site 
FiGURe 4 | (A–C) Resection of ulcerative breast carcinoma and subsequent 
chest wall reconstruction with implantation of polypropylene mesh and 
cranially pedicled TRAM flap plasty.
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defect, the latissimus dorsi flap has proven itself in the coverage 
of thoracic wall defects (9, 20, 44, 48, 49). Because of its volume, 
it can also seal intrathoracic defects and dead space. The large 
caliber of the vascular pedicle with a diameter of 2–4 mm will 
also permit immediate microsurgical transfer if necessary (50).
OMeNTUM MAJUS FLAP
The omentum majus flap is an alternative option for closing defects 
in the anterior thoracic wall when the aforementioned pedicled 
flaps or free flaps flap are not suitable. It is also an option to cover 
large defects with small volumes. Pedicled to the unilateral or 
bilateral gastro-omental vessels, it can be lifted via a paramedian 
incision from the xiphoid process to beneath the umbilicus (51, 
52). The size of the omentum majus flap can only be determined 
reliably under direct visual control after surgical exposition. 
Especially after previous abdominal surgery, adhesions must be 
removed and the omentum majus raised from the stomach to 
achieve the appropriate rotatory radius. Furthermore, a breach 
must remain in the cranial abdominal wall so that the pedicle 
can be guided through it toward the thoracic wall. Consequently, 
this flap should be raised only by experienced surgeons who 
can manage potential intra-abdominal complications such as 
intestinal perforations and bleeding. Due to its great plasticity, the 
omentum is well suited for sealing dead space. However, it must 
always be covered by split skin graft and partial secondary healing 
can occur due to persistent serous discharge from the fatty tissue. 
Because of the high risk for the development of epigastric hernia 
and the aforementioned disadvantages, the pedicled omentum 
majus remains principally a fallback option when other proce-
dures are not suitable (53, 54).
FRee FLAP PLASTieS
Previous operations, axillary lymph dissection, or radiotherapy 
can prevent pedicled flaps from being utilized for soft-tissue cov-
erage. In these situations, free flaps form an additional and pivotal 
tool in the armamentarium of plastic surgery. Fasciocutaneous 
or myocutaneous flaps from the back (latissimus dorsi flap, 
parascapular flap) or the thigh [anterior lateral thigh (ALT); ten-
sor fasciae latae (TFL)] are some free flaps regularly used at our 
institution. Another frequently used donor area is the abdominal 
region with the TRAM flap or its muscle-preserving variation 
(ms-TRAM) as well as the perforator-based deep inferior epigas-
tric artery perforator flap (DIEP).
The internal mammary artery is the primary connecting ves-
sel at the anterior thoracic wall. At the lateral thoracic wall, the 
thoracodorsal vessels can act as sufficient connectors. In the event 
that these are not available, an arteriovenous loop between the 
cephalic vein and the thoracoacromial artery can constitute an 
effort-intensive but feasible solution (55).
The donor-site morbidity of free flaps is moderate and well 
tolerated by most patients, especially if the donor site can be 
closed primarily (50, 56, 57).
PULMONARY FUNCTiON, QUALiTY OF 
LiFe, AND MORTALiTY
In our patient population, thoracic wall reconstruction-impaired 
pulmonary function parameters vary only slightly (9). The most 
significant alteration was found in the forced expiratory volume 
in 1 s (FEV1), which was decreased by approximately 18%. This 
observed reduction of FEV1 might be the consequence of the loss 
FiGURe 5 | (A–D) Resection of a recurrent high-grade chondrosarcoma and chest wall reconstruction utilizing latissimus dorsi flap with split skin graft coverage of 
the flap donor site.
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of the intercostal muscles. However, the extent of chest wall resec-
tion was not found to be a significant predictor of pulmonary 
function alteration. In fact, breathing pain affected respiratory 
function in a significant manner, whereas the extent of resection 
surprisingly did not correlate with breathing pain. Partial lung 
resection also did not significantly impair pulmonary function. 
Similar findings were also observed in other studies in which 
pulmonary function was only slightly affected by thoracic wall 
resection (58–60). Reviewing our own data, hospitalization at our 
institution averaged 20.7 days (range, 6–89), and patients were 
in the intensive care unit for 6  days on average (range, 0–74). 
Patients were mechanically ventilated for 2.7 days postoperatively 
(range, 0–62) (9).
Thoracic wall resection and reconstruction are associated 
with significant morbidity reducing nearly all daily life activities 
(9). However, a certain degree of selection bias in such assess-
ments must be acknowledged. The patients interviewed here 
represented the healthier and more active patients. These patients 
sensed postoperative restrictions more than those patients who 
were treated in palliative intention because of pain and ulcerated 
lesions. However, with respect to the malignancy of the underly-
ing disease, these restrictions might be justified. In our patient 
population, the majority of the treated and interviewed patients 
would undergo the procedure again (9).
Effective treatment modalities have improved the survival 
of patients with thoracic wall tumors in recent decades (61). At 
our institute, the 5-year overall survival rate for patients with 
malignant chest wall tumors including soft-tissue sarcomas and 
breast carcinoma was approximately 56% (9). For chest wall sar-
comas, the 5-year overall survival rates were approximately 52%. 
Other studies have presented similar overall survival rates (7, 14, 
62, 63). In an analysis of 127 full-thickness resections for chest 
wall sarcomas, Wouters et  al. demonstrated that full-thickness 
chest wall resection represents a safe and effective procedure, 
with a limited number of complications and an adequate long-
term survival. For primary chest wall sarcomas, these authors 
reported a 5-year survival rate of 63% and for recurrent sarcomas 
50% (14). Furthermore, adjuvant radiotherapy was associated 
with increased local disease control. In the treatment of locally 
advanced or recurrent breast carcinomas, full-thickness chest 
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wall resection was also associated with an acceptable morbidity 
and a 5-year overall survival rate of 63% after surgery (64).
CONCLUSiON
In curative treatment regimens, chest wall reconstruction ena-
bles the complete resection of tumors and subsequent adjuvant 
radiotherapy. Even at advanced localized disease stages or in a 
palliative treatment setting, safe and reliable techniques allow the 
removal of large ulcerative tumors. As a reconstructive option 
after tumor resection, local flaps represent a reliable tool that 
can cover most thoracic wall defects. Nevertheless, concerns 
over distant iatrogenic implantation of tumor cells at the donor 
site of local flaps do exist when tumor resection and flap cover-
age are performed during the same surgery. In the literature, 
unfortunately, there has been no systematic analysis of this 
issue. However, iatrogenic tumor metastases, especially sarcoma 
metastases, at donor-tissue sites after local flap reconstruction are 
a rare occurrence and should not preclude the use of local flap 
reconstruction (65). They have been reported only in selected 
case reports (66). Further, the effect of donor-site radiation on the 
incidence of iatrogenic sarcoma metastases still remains unclear 
and should be examined (65).
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agulation regimens are less stringent. However, there has been a 
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October 2015 | Volume 5 | Article 2479
Harati et al. Thoracic wall reconstruction after tumor resection
Frontiers in Oncology | www.frontiersin.org
11. Daigeler A, Zmarsly I, Hirsch T, Goertz O, Steinau HU, Lehnhardt M, et al. 
Long-term outcome after local recurrence of soft tissue sarcoma: a retro-
spective analysis of factors predictive of survival in 135 patients with locally 
recurrent soft tissue sarcoma. Br J Cancer (2014) 110(6):1456–64. doi:10.1038/
bjc.2014.21 
12. Kandel R, Coakley N, Werier J, Engel J, Ghert M, Verma S, et al. Surgical 
margins and handling of soft-tissue sarcoma in extremities: a clinical 
practice guideline. Curr Oncol (2013) 20(3):e247–54. doi:10.3747/
co.20.1308 
13. Gross JL, Younes RN, Haddad FJ, Deheinzelin D, Pinto CA, Costa ML. 
Soft-tissue sarcomas of the chest wall: prognostic factors. Chest (2005) 
127(3):902–8. doi:10.1378/chest.127.3.902 
14. Wouters MW, van Geel AN, Nieuwenhuis L, van Tinteren H, Verhoef C, van 
Coevorden F, et al. Outcome after surgical resections of recurrent chest wall 
sarcomas. J Clin Oncol (2008) 26(31):5113–8. doi:10.1200/JCO.2008.17.4631 
15. Lindford AJ, Jahkola TA, Tukiainen E. Late results following flap reconstruc-
tion for chest wall recurrent breast cancer. J Plast Reconstr Aesthet Surg (2013) 
66(2):165–73. doi:10.1016/j.bjps.2012.09.027 
16. Lardinois D, Muller M, Furrer M, Banic A, Gugger M, Krueger T, et  al. 
Functional assessment of chest wall integrity after methylmethacrylate 
reconstruction. Ann Thorac Surg (2000) 69(3):919–23. doi:10.1016/
S0003-4975(99)01422-8 
17. Deschamps C, Tirnaksiz BM, Darbandi R, Trastek VF, Allen MS, Miller DL, 
et al. Early and long-term results of prosthetic chest wall reconstruction. J Thorac 
Cardiovasc Surg (1999) 117(3):588–91. doi:10.1016/S0022-5223(99)70339-9 
18. Daigeler A, Harati K, Goertz O, Hirsch T, Behr B, Lehnhardt M, et al. Thoracic 
wall reconstruction in advanced breast tumours. Geburtshilfe Frauenheilkd 
(2014) 74(6):548–56. doi:10.1055/s-0033-1360321 
19. Losken A, Thourani VH, Carlson GW, Jones GE, Culbertson JH, Miller 
JI, et  al. A reconstructive algorithm for plastic surgery following extensive 
chest wall resection. Br J Plast Surg (2004) 57(4):295–302. doi:10.1016/j.
bjps.2004.02.004 
20. Arnold PG, Pairolero PC. Chest-wall reconstruction: an account of 
500 consecutive patients. Plast Reconstr Surg (1996) 98(5):804–10. 
doi:10.1097/00006534-199610000-00008 
21. Mahabir RC, Butler CE. Stabilization of the chest wall: autologous and 
alloplastic reconstructions. Semin Plast Surg (2011) 25(1):34–42. doi:10.105
5/s-0031-1275169 
22. Netscher DT, Izaddoost S, Sandvall B. Complications, pitfalls, and outcomes 
after chest wall reconstruction. Semin Plast Surg (2011) 25(1):86–97. doi:10.
1055/s-0031-1275175 
23. Daigeler A, Drucke D, Tatar K, Homann HH, Goertz O, Tilkorn D, et al. The 
pedicled gastrocnemius muscle flap: a review of 218 cases. Plast Reconstr Surg 
(2009) 123(1):250–7. doi:10.1097/PRS.0b013e3181904e2e 
24. Vogt PM, Busch K, Peter FW, Mocklinghoff C, Torres A, Steinau HU. [Plastic 
reconstruction of the irradiated thoracic wall]. Langenbecks Arch Chir Suppl 
Kongressbd (1998) 115:507–11. 
25. Thomas PA, Brouchet L. Prosthetic reconstruction of the chest wall. Thorac 
Surg Clin (2010) 20(4):551–8. doi:10.1016/j.thorsurg.2010.06.006 
26. Fouad FA. Chest wall resection and reconstruction: analysis of 11 cases 
after methylmethacrylate reconstruction. J Egypt Natl Canc Inst (2006) 
18(3):175–82. 
27. Vartanian SM, Colaco S, Orloff LE, Theodore PR. Oklahoma prosthesis: 
resection of tumor of clavicle and chest wall reconstructed with a custom 
composite graft. Ann Thorac Surg (2006) 82(1):332–4. doi:10.1016/j.
athoracsur.2005.09.029 
28. Weyant MJ, Bains MS, Venkatraman E, Downey RJ, Park BJ, Flores RM, 
et  al. Results of chest wall resection and reconstruction with and without 
rigid prosthesis. Ann Thorac Surg (2006) 81(1):279–85. doi:10.1016/j.
athoracsur.2005.07.001 
29. Chapelier AR, Missana MC, Couturaud B, Fadel E, Fabre D, Mussot S, et al. 
Sternal resection and reconstruction for primary malignant tumors. Ann 
Thorac Surg (2004) 77(3):1001–6. doi:10.1016/j.athoracsur.2003.08.053 
30. Akiba T, Marushima H, Nogi H, Kamiya N, Kinoshita S, Takeyama H, 
et  al. Chest wall reconstruction using Gore-Tex(R) dual mesh. Ann Thorac 
Cardiovasc Surg (2012) 18(2):166–9. doi:10.5761/atcs.cr.11.01718 
31. Watanabe A, Watanabe T, Obama T, Ohsawa H, Mawatari T, Ichimiya Y, 
et  al. New material for reconstruction of the anterior chest wall, including 
the sternum. J Thorac Cardiovasc Surg (2003) 126(4):1212–4. doi:10.1016/
S0022-5223(03)00933-4 
32. Berthet JP, Canaud L, D’Annoville T, Alric P, Marty-Ane CH. Titanium 
plates and Dualmesh: a modern combination for reconstructing very large 
chest wall defects. Ann Thorac Surg (2011) 91(6):1709–16. doi:10.1016/j.
athoracsur.2011.02.014 
33. Girotti P, Leo F, Bravi F, Tavecchio L, Spano A, Cortinovis U, et al. The “rib-
like” technique for surgical treatment of sternal tumors: lessons learned from 
101 consecutive cases. Ann Thorac Surg (2011) 92(4):1208–15. doi:10.1016/j.
athoracsur.2011.05.016 
34. Turna A, Kavakli K, Sapmaz E, Arslan H, Caylak H, Gokce HS, et  al. 
Reconstruction with a patient-specific titanium implant after a wide anterior 
chest wall resection. Interact Cardiovasc Thorac Surg (2014) 18(2):234–6. 
doi:10.1093/icvts/ivt408 
35. Song DH, Lohman RF, Renucci JD, Jeevanandam V, Raman J. Primary sternal 
plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg 
(2004) 26(2):367–72. doi:10.1016/j.ejcts.2004.04.038 
36. Lee JC, Raman J, Song DH. Primary sternal closure with titanium plate 
fixation: plastic surgery effecting a paradigm shift. Plast Reconstr Surg (2010) 
125(6):1720–4. doi:10.1097/PRS.0b013e3181d51292 
37. Raman J, Song DH, Bolotin G, Jeevanandam V. Sternal closure with tita-
nium plate fixation  –  a paradigm shift in preventing mediastinitis. Interact 
Cardiovasc Thorac Surg (2006) 5(4):336–9. doi:10.1510/icvts.2005.121863 
38. Matros E, Disa JJ. Uncommon flaps for chest wall reconstruction. Semin Plast 
Surg (2011) 25(1):55–9. doi:10.1055/s-0031-1275171 
39. Skoracki RJ, Chang DW. Reconstruction of the chestwall and thorax. J Surg 
Oncol (2006) 94(6):455–65. doi:10.1002/jso.20482 
40. Ariyan S. The pectoralis major myocutaneous flap. A versatile flap for 
reconstruction in the head and neck. Plast Reconstr Surg (1979) 63(1):73–81. 
doi:10.1097/00006534-197901000-00012 
41. Bakri K, Mardini S, Evans KK, Carlsen BT, Arnold PG. Workhorse flaps 
in chest wall reconstruction: the pectoralis major, latissimus dorsi, and 
rectus abdominis flaps. Semin Plast Surg (2011) 25(1):43–54. doi:10.105
5/s-0031-1275170 
42. Daigeler A, Falkenstein A, Pennekamp W, Duchna HW, Jettkant B, Goertz 
O, et  al. Sternal osteomyelitis: long-term results after pectoralis muscle 
flap reconstruction. Plast Reconstr Surg (2009) 123(3):910–7. doi:10.1097/
PRS.0b013e318199f49f 
43. Mathes SJ. Chest wall reconstruction. Clin Plast Surg (1995) 22(1):187–98. 
44. Beahm EK, Chang DW. Chest wall reconstruction and advanced disease. 
Semin Plast Surg (2004) 18(2):117–29. doi:10.1055/s-2004-829046 
45. Daigeler A, Simidjiiska-Belyaeva M, Drucke D, Goertz O, Hirsch T, Soimaru 
C, et al. The versatility of the pedicled vertical rectus abdominis myocutaneous 
flap in oncologic patients. Langenbecks Arch Surg (2011) 396(8):1271–9. 
doi:10.1007/s00423-011-0823-6 
46. Rowsell AR, Davies DM, Eisenberg N, Taylor GI. The anatomy of the subscap-
ular-thoracodorsal arterial system: study of 100 cadaver dissections. Br J Plast 
Surg (1984) 37(4):574–6. doi:10.1016/0007-1226(84)90152-8 
47. Rowsell AR, Eisenberg N, Davies DM, Taylor GI. The anatomy of the tho-
racodorsal artery within the latissimus dorsi muscle. Br J Plast Surg (1986) 
39(2):206–9. doi:10.1016/0007-1226(86)90083-4 
48. Arnold PG, Lovich SF, Pairolero PC. Muscle flaps in irradiated wounds: an 
account of 100 consecutive cases. Plast Reconstr Surg (1994) 93(2):324–7. 
doi:10.1097/00006534-199402000-00016 
49. Arnold PG, Pairolero PC. Surgical management of the radiated chest wall. Plast 
Reconstr Surg (1986) 77(4):605–12. doi:10.1097/00006534-198604000-00016 
50. Sauerbier M, Dittler S, Kreutzer C. Microsurgical chest wall reconstruction 
after oncologic resections. Semin Plast Surg (2011) 25(1):60–9. doi:10.105
5/s-0031-1275172 
51. Lee AB Jr, Schimert G, Shaktin S, Seigel JH. Total excision of the sternum and 
thoracic pedicle transposition of the greater omentum; useful strategems in 
managing severe mediastinal infection following open heart surgery. Surgery 
(1976) 80(4):433–6. 
52. Arnold PG, Witzke DJ, Irons GB, Woods JE. Use of omental transposition 
flaps for soft-tissue reconstruction. Ann Plast Surg (1983) 11(6):508–12. 
doi:10.1097/00000637-198312000-00010 
53. Hultman CS, Culbertson JH, Jones GE, Losken A, Kumar AV, 
Carlson GW, et  al. Thoracic reconstruction with the omentum: 
October 2015 | Volume 5 | Article 24710
Harati et al. Thoracic wall reconstruction after tumor resection
Frontiers in Oncology | www.frontiersin.org
indications, complications, and results. Ann Plast Surg (2001) 46(3):242–9. 
doi:10.1097/00000637-200103000-00007 
54. Jurkiewicz MJ, Arnold PG. The omentum: an account of its use in 
the reconstruction of the chest wall. Ann Surg (1977) 185(5):548–54. 
doi:10.1097/00000658-197705000-00007 
55. Reichenberger MA, Harenberg PS, Pelzer M, Gazyakan E, Ryssel H, 
Germann G, et al. Arteriovenous loops in microsurgical free tissue transfer 
in reconstruction of central sternal defects. J Thorac Cardiovasc Surg (2010) 
140(6):1283–7. doi:10.1016/j.jtcvs.2010.05.019 
56. Fischer S, Klinkenberg M, Behr B, Hirsch T, Kremer T, Hernekamp F, et al. 
Comparison of donor-site morbidity and satisfaction between anterolateral 
thigh and parascapular free flaps in the same patient. J Reconstr Microsurg 
(2013) 29(8):537–44. doi:10.1055/s-0033-1351394 
57. Klinkenberg M, Fischer S, Kremer T, Hernekamp F, Lehnhardt M, Daigeler A. 
Comparison of anterolateral thigh, lateral arm, and parascapular free flaps with 
regard to donor-site morbidity and aesthetic and functional outcomes. Plast 
Reconstr Surg (2013) 131(2):293–302. doi:10.1097/PRS.0b013e31827786bc 
58. Meadows JA III, Staats BA, Pairolero PC, Rodarte JR, Arnold PG. Effect 
of resection of the sternum and manubrium in conjunction with muscle 
transposition on pulmonary function. Mayo Clin Proc (1985) 60(9):604–9. 
doi:10.1016/S0025-6196(12)60984-7 
59. Kohman LJ, Auchincloss JH, Gilbert R, Beshara M. Functional results of 
muscle flap closure for sternal infection. Ann Thorac Surg (1991) 52(1):102–6. 
doi:10.1016/0003-4975(91)91428-X 
60. Klesius AA, Dzemali O, Simon A, Kleine P, Abdel-Rahman U, Herzog C, et al. 
Successful treatment of deep sternal infections following open heart surgery by 
bilateral pectoralis major flaps. Eur J Cardiothorac Surg (2004) 25(2):218–23. 
doi:10.1016/j.ejcts.2003.11.019 
61. Tukiainen E. Chest wall reconstruction after oncological resections. Scand J 
Surg (2013) 102(1):9–13. doi:10.1177/145749691310200103 
62. Chapelier A, Macchiarini P, Rietjens M, Lenot B, Margulis A, Petit 
JY, et  al. Chest wall reconstruction following resection of large pri-
mary malignant tumors. Eur J Cardiothorac Surg (1994) 8(7):351–6. 
doi:10.1016/1010-7940(94)90028-0 
63. Walsh GL, Davis BM, Swisher SG, Vaporciyan AA, Smythe WR, Willis-
Merriman K, et  al. A single-institutional, multidisciplinary approach 
to primary sarcomas involving the chest wall requiring full-thickness 
resections. J Thorac Cardiovasc Surg (2001) 121(1):48–60. doi:10.1067/
mtc.2001.111381 
64. Levy Faber D, Fadel E, Kolb F, Delaloge S, Mercier O, Mussot S, et al. Outcome 
of full-thickness chest wall resection for isolated breast cancer recurrence. Eur 
J Cardiothorac Surg (2013) 44(4):637–42. doi:10.1093/ejcts/ezt105 
65. Saba SC, Shaterian A, Tokin C, Dobke MK, Wallace AM. The pedicled 
myocutaneous flap as a choice reconstructive technique for immediate adju-
vant brachytherapy in sarcoma treatment. Curr Oncol (2012) 19(6):e491–5. 
doi:10.3747/co.19.1141 
66. Hughes TM, Thomas JM. Sarcoma metastases due to iatrogenic implantation. 
Eur J Surg Oncol (2000) 26(1):50–2. doi:10.1053/ejso.1999.0740 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2015 Harati, Kolbenschlag, Behr, Goertz, Hirsch, Kapalschinski, Ring, 
Lehnhardt and Daigeler. This is an open-access article distributed under the terms 
of the Creative Commons Attribution License (CC BY). The use, distribution or 
reproduction in other forums is permitted, provided the original author(s) or licensor 
are credited and that the original publication in this journal is cited, in accordance 
with accepted academic practice. No use, distribution or reproduction is permitted 
which does not comply with these terms.
